2024 (v1)
Publication
No description
Uploaded on: September 20, 2024
G
A
Last name: GRAVINA
First name: Antonietta Gerarda
No description
Regorafenib, an oral multikinase inhibitor, has demonstrated survival benefit in metastatic colorectal cancer (mCRC) patients that have progressed after all standard therapies. However, novel strategies to improve tolerability and enhance anti-cancer efficacy are needed.